Study of umbilical cord blood cells for radiation lung injury
Part of Lungs & breathing clinical trials.
This trial tests a treatment made from umbilical cord blood cells for people with lung damage from chest radiation. It aims to see if it is safe and can help when standard treatments haven't worked.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have had chest radiation therapy and now have grade 2-3 radiation lung injury
- Standard treatment has not helped or your symptoms are getting worse after two weeks
- Your cancer has been well controlled for at least 3 months
- You have no serious heart, liver, or kidney problems
- You are willing to follow the study plan and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special type of stem cells (from umbilical cord blood) can help heal chronic bowel damage caused by radiation therapy. It is for people whose bowel symptoms, like diarrhea or pain, continue despite standard treatment.
This study looks at cells from the lungs of people who developed lung inflammation after chest radiation for cancer. It aims to understand why some people get this reaction, which may help find better treatments.
This trial tests a drug called nintedanib to see if it can prevent radiation-related lung inflammation (pneumonia) in people with lung cancer that cannot be surgically removed. It may help protect your lungs during radiation treatment.
This trial tests if adding BIO 300 to chest radiation is safe and helps people who have both non-small cell lung cancer (early stage) and interstitial lung disease (scarring of the lungs). It aims to find better treatment options for this specific group.
This trial is looking at how well a lung cancer treatment improves survival. It enrolls adults with confirmed lung cancer who can safely take the study medicines and have cancer that can be measured on scans.
This early-stage trial tests a new treatment using extracts from human umbilical cord stem cells, given by inhalation, to see if it is safe and can help patients with interstitial lung disease (a condition where lung tissue becomes scarred and stiff). The study will measure whether this approach reduces symptoms and improves how well your lungs work.
Hear when a new Radiation-induced Lung Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.